Class II recall Z-0143-2027: Boston Scientific Corporation

Class II recall Z-0143-2027: Boston Scientific Corporation (Massachusetts): Boston Scientific Corporation. Dated 14 days ago, it is in the active follow-up window. Score 68/100. As of 2026-11-03, from U.S. FDA openFDA (510(k) clearances and device enforcement reports).

Data as of · Compiled by Zalwin from U.S. FDA openFDA (510(k) clearances and device enforcement reports)

Free preview: all 14 published fields of this record are shown below. Locked: 40 related MA FDAPulse records and the 5-column CSV export.

FieldValue
RecordDevice recall
Recall numberZ-0143-2027
Recalling firmBoston Scientific Corporation
ClassificationClass II
StatusOngoing
Voluntary / mandatedVoluntary: Firm initiated
SpecialtyOther
ProductNaviFlex LW Pusher; Advx Panc. Stent 4/5F; Material Number (UPN): M00535030;
ReasonDevice was incorrectly manufactured with a guidewire exit port (referred to in the IFU as the RX port), which is not a design feature associated with this device configuration.
Quantity403
DistributionUS Nationwide distribution in the states of AL, CA, FL, GA, IL, IN, KY, MD, NC, NH, NM, NY, RI, TX, WA, WI, WV and the countries in TBD.
Recall initiated2026-09-10
Reported2026-10-21
Firm locationMarlborough, MA, United States
Peer records CSV (41 MA records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch Class II recall Z-0143-2027: Boston Scientific Corporation

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock Class II recall Z-0143-2027: Boston Scientific + all 41 MA records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Record · Specialty · Date · Review days · Recall class · official source URL

  • Source agency: U.S. FDA openFDA (510(k) clearances and device enforcement reports)
  • Record date: 2026-10-21
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all MA records free →

Top FDAPulse records (MA first): GSPE Spacer (K260063) · Sensinel Cardiopulmonary Management (CPM) System (K260801) · multiFiltratePRO System (K261203) · a2z-Abdo-Triage (K260906) · BodyTom 64 (NL4100); OmniTom Elite (NL5000) (K261125) · Browse all by state and category →

LIVE PUBLIC DATA Source: U.S. FDA openFDA (510(k) clearances and device enforcement reports) · Last refreshed: Tue, 03 Nov 2026 18:05:14 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: Class II recall Z-0143-2027: Boston Scientific Corporation and 41 Massachusetts peers

  • Massachusetts FDAPulse records like this one: 41
  • Timing: Medium: dated in the last 30 days
  • Estimated pipeline if you contact every Massachusetts peer: $8,200 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more FDAPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

68 / 100 Predicate Speed & CAPA Advisory Opportunity Score

  • Class II recall: usually triggers CAPA and quality-system remediation work.
  • Recall is still ongoing.
  • Posted 14 days ago.

What is the FDAPulse record for Class II recall Z-0143-2027: Boston Scientific Corporation in Massachusetts?

Class II device recall Z-0143-2027 by Boston Scientific Corporation: Device was incorrectly manufactured with a guidewire exit port (referred to in the IFU as the RX port), which is not a d

How does Class II recall Z-0143-2027: Boston Scientific Corporation compare to other Massachusetts FDAPulse records?

It is fresh: dated 14 days ago, inside the window where early outreach matters most.

Class II recall Z-0143-2027 vs. top 3 peers

OrganizationLocationRecord date
Class II recall Z-0143-2027MA2026-10-21
Class II recall Z-3155-2026MA2026-10-07
Class II recall Z-0232-20272026-10-28
Class II recall Z-0243-20272026-10-28

Related records

Recent FDA Class II device recalls

More Massachusetts public-record feeds

FEMA Hazard Mitigation Project Tracker in Massachusetts Nursing Home Inspection Deficiencies by State & Severity in Massachusetts Federal Alcohol Permit Holder Directory in Massachusetts New NIH Research Awards by Organization in Massachusetts New FDA Medical Device Listings by Manufacturer, CMO & Sterilizer in Massachusetts School & Library E-Rate Contracts Up for Rebid in Massachusetts New & Re-Approved E-Rate Service Providers (FCC Form 498 / SPIN) in Massachusetts New FDA PMA Device, NDA, Generic (ANDA), BLA & Drug Supplement Approvals by Sponsor in Massachusetts

How to monitor Class II recall Z-0143-2027: Boston Scientific Corporation and peer other records

Get new FDAPulse records like Class II recall Z-0143-2027: Boston Scientific Corporation by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get clearances and recalls like this every day

FDAPulse emails new 510(k) clearances and recalls for your specialties and competitors.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Data from the FDA openFDA API, which may lag official FDA databases. Informational only; not regulatory or legal advice.

Often used together

Or get the Healthcare Vendor Bundle for $14.99 one-time: Full CSV unlocks for group practices and FDA clearances/recalls.